Literature DB >> 15940562

ENT Wegener's granulomatosis can hide severe central nervous system involvement.

B Tumiati1, G Zuccoli, L Pavone, C Buzio.   

Abstract

The clinical manifestations of localised or early systemic forms of Wegener's granulomatosis (WG) do not require immediate treatment to save the patient's life and/or the function of a vital organ. The organs mainly involved are the ear, nose, throat (ENT) and lung, and the results of antineutrophil cytoplasmic antibody (ANCA) assays are frequently negative. We here describe three cases of the ANCA-negative early systemic form of WG with prevalent ENT involvement complicated by severe central nervous system (CNS) disease; in two cases, the only symptom was a mild headache. We conclude that, although apparently mild, the localised and early systemic forms of WG can hide CNS involvement and may require immediate treatment. This complication should be suspected and investigated in the case of patients with localised or early systemic disease especially in the presence of ENT involvement and negative ANCA assays.

Entities:  

Mesh:

Year:  2004        PMID: 15940562     DOI: 10.1007/s10067-004-1025-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  Wegener granulomatosis: MR imaging findings in brain and meninges.

Authors:  J M Murphy; B Gomez-Anson; J H Gillard; N M Antoun; J Cross; J D Elliott; M Lockwood
Journal:  Radiology       Date:  1999-12       Impact factor: 11.105

2.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

Authors:  R Y Leavitt; A S Fauci; D A Bloch; B A Michel; G G Hunder; W P Arend; L H Calabrese; J F Fries; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

3.  The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis.

Authors:  J K Rao; M Weinberger; E Z Oddone; N B Allen; P Landsman; J R Feussner
Journal:  Ann Intern Med       Date:  1995-12-15       Impact factor: 25.391

Review 4.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

5.  Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature.

Authors:  E Reinhold-Keller; K de Groot; K Holl-Ulrich; A C Arlt; M Heller; A C Feller; W L Gross
Journal:  Clin Exp Rheumatol       Date:  2001 Sep-Oct       Impact factor: 4.473

Review 6.  Update on the European Vasculitis Study Group trials.

Authors:  D Jayne
Journal:  Curr Opin Rheumatol       Date:  2001-01       Impact factor: 5.006

7.  A brief history of Wegener's granulomatosis: on limited, localized, and generalized forms of the disease: comment on the article by the Wegener's Granulomatosis Etanercept Trial Research Group.

Authors:  Peter Lamprecht; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2004-01

8.  Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic.

Authors:  H Nishino; F A Rubino; R A DeRemee; J W Swanson; J E Parisi
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

9.  Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.

Authors:  John H Stone
Journal:  Arthritis Rheum       Date:  2003-08
  9 in total
  2 in total

Review 1.  Pituitary involvement in patients with granulomatosis with polyangiitis: case series and literature review.

Authors:  Yu Gu; Xuefeng Sun; Min Peng; Ting Zhang; Juhong Shi; Jiangfeng Mao
Journal:  Rheumatol Int       Date:  2019-06-15       Impact factor: 2.631

2.  Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis.

Authors:  Hyun Ah Choi; Mi Ji Lee; Chin-Sang Chung
Journal:  J Neurol       Date:  2017-02-20       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.